Funding opportunity: Nonsurgical permanent female contraception

The Oregon Permanent Contraception Research Center (OPERM) is soliciting applications for research funding for preclinical studies of promising novel approaches to female permanent, or very long acting (>10 -20 years), contraception. A variety of funding opportunities are available.

OPERM was established at the Oregon National Primate Research Center, Oregon Health & Science University in November, 2014 through a generous grant from the Bill & Melinda Gates Foundation. The Center will provide grants for direct research costs (up to $300,000/year) and core resources (including use of the nonhuman primate model for proof-of-concept testing) designed to support early phase studies. Applications from clinicians, material scientists, social scientists, bioengineers, immunologists, and reproductive biologists and others are welcome. Proposals may involve novel targets or approaches, or the use of a new technology or innovation to address limitations or problems with previously investigated techniques. All proposals should address the target product profile of a new permanent contraception method; low cost, portability, applicability for use in low resource settings by non-physicians, single treatment, and lack of interference with normal menstrual cycles. Approaches that adapt currently approved drugs or technologies from other fields are particularly welcomed.

Applicants are required to submit a proposal outline in the specified format as a Letter of Intent by May 31, 2016. These proposal outlines will be reviewed, and selected applicants will be invited to submit a complete research proposal.

Complete details and a downloadable copy of the full Request for Proposals are available on the center’s website or by contacting the OPERM Administrative Coordinator, Keri Brown (

Applicants are encouraged to contact the OPERM co-Principal Investigators to discuss potential projects:

Jeffrey T. Jensen, M.D., M.P.H.,
Ov D. Slayden, Ph.D.,